UK aid and Unilever reach one billion people with global hygiene campaign to tackle Covid-19
|
One billion people in developing countries have now been reached
with advice, hygiene products and access to handwashing facilities
in a campaign launched between the UK government and British
business Unilever to reduce the spread of Covid-19. Working through
the UN, charities and other partners, the campaign has: Trained
140,000 staff, including...Request free
trial
One billion people in developing countries have now been reached with advice, hygiene products and access to handwashing facilities in a campaign launched between the UK government and British business Unilever to reduce the spread of Covid-19. Working through the UN, charities and other partners, the campaign has:
The UK has been leading the international response to the Covid-19 pandemic, helping to develop and distribute vaccines support the global economy and bolster health systems around the world. As one of the largest donors to the COVAX AMC, the UK is also helping stop the spread of the disease through global vaccinations. The scheme has reached 100 countries so far. The Prime Minister has also confirmed the UK will share the majority of any future surplus coronavirus vaccines from our supply with the COVAX procurement pool to support developing countries. Foreign, Commonwealth & Development Office Minister Wendy Morton said:
As well as the UK Government and Unilever, the campaign, funded by UK aid and Unilever, is also supported by experts from the London School of Hygiene & Tropical Medicine and 21 partners including UNICEF and the United Nations High Commissioner for Refugees who are helping governments around the world on their own Covid-19 responses. Charities and international organisations have developed new tools to communicate how Covid-19 is spread. Population Services International developed a WhatsApp chatbot to send new training to health workers while remaining socially-distanced and safe. Rebecca Marmot, Chief Sustainability Officer at Unilever, said:
Robert Dreibelbis, from the London School of Hygiene & Tropical Medicine, said:
|
